In the present study, the TNF-inhibitors analyzed were adalimumab (1 case), etanercept (5 cases) and golimumab (4 cases), which restored the frequency of IgD-CD27- memory B cells in RA patients to normal levels. The gene discussed is TNF; the disease is rheumatoid arthritis.